Hemostasis Today

June, 2026
June 2026
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Peter Feldman Highlights Hereditary Factor X Deficiency Day and the Impact of Coagadex Production at Kedrion’s BPL Site
Oct 11, 2025, 08:30

Peter Feldman Highlights Hereditary Factor X Deficiency Day and the Impact of Coagadex Production at Kedrion’s BPL Site

Peter Feldman, Director of Pharmaceuticals and Healthcare at Queen’s House Consulting, shared on LinkedIn:

On Hereditary Factor X Deficiency Day (10/10), I have been visiting Kedrion’s BPL site in Elstree, UK, meeting some of the one-in-ten-million people* who manufacture Coagadex factor X concentrate for the one-in-one-million people** living with factor X deficiency.

Great to meet friends old and new who maintain supply of this ultra-orphan drug product, purified from human blood plasma (coincidently, it is also International Plasma Awareness Week).

Sorry not to tag you all, but it would exceed my character-count allowance!

In an age where pharma companies are simultaneously celebrated for their innovation and castigated for their commercialism, it important to recognise the needs of people who live life to the max alongside their coagulation factor deficiency and the individual commitment of people across the plasma industry who strive to facilitate this.

*approximately 8 billion people on the planet and approximately 1000 people on the Elstree site = 1 in 10 million (rounded up).”

Read the full factsheet here.

Peter Feldman Highlights Hereditary Factor X Deficiency Day and the Impact of Coagadex Production at Kedrion’s BPL Site

Stay updated with Hemostasis Today.